• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent.聚肌胞包覆普鲁士蓝纳米颗粒作为一种双重模式的 HIV 潜伏逆转剂。
Nanomedicine (Lond). 2022 Dec;17(29):2159-2171. doi: 10.2217/nnm-2022-0311. Epub 2023 Feb 3.
2
Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV.纳米囊泡包封潜伏逆转剂和广谱中和抗体增强自然杀伤细胞对潜伏 HIV 体外模型的细胞毒性。
Int J Nanomedicine. 2023 Jul 25;18:4055-4066. doi: 10.2147/IJN.S401304. eCollection 2023.
3
Establishment, Persistence, and Reactivation of Latent HIV-1 Infection in Renal Epithelial Cells.潜伏 HIV-1 感染在肾上皮细胞中的建立、持续存在和再激活。
J Virol. 2022 Jul 27;96(14):e0062422. doi: 10.1128/jvi.00624-22. Epub 2022 Jul 5.
4
Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4 T Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.马拉维若与潜伏 HIV-1 再激活有关,通过抑制性抗逆转录病毒治疗的 HIV 感染者静息 CD4 T 细胞中 NF-κB 的激活。
J Virol. 2018 Apr 13;92(9). doi: 10.1128/JVI.01931-17. Print 2018 May 1.
5
TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4 T Cells.TLR1/2 激动剂增强 HIV-1 潜伏期的逆转,并促进 NK 细胞诱导抑制 HIV-1 感染的自体 CD4 T 细胞。
J Virol. 2021 Aug 10;95(17):e0081621. doi: 10.1128/JVI.00816-21.
6
Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.由广泛中和抗体的单链Fv引导的嵌合抗原受体T细胞可特异性有效地根除从接受抑制性联合抗逆转录病毒疗法的HIV-1感染个体分离出的CD4 + T淋巴细胞中潜伏激活的病毒。
J Virol. 2016 Oct 14;90(21):9712-9724. doi: 10.1128/JVI.00852-16. Print 2016 Nov 1.
7
Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents.HIV-1 潜伏逆转剂联合应用中的协同作用与疗效权衡。
PLoS Comput Biol. 2018 Feb 16;14(2):e1006004. doi: 10.1371/journal.pcbi.1006004. eCollection 2018 Feb.
8
Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.潜伏 HIV-1 前病毒的 NF-κB 非依赖性信号再激活。
J Virol. 2019 Aug 28;93(18). doi: 10.1128/JVI.00495-19. Print 2019 Sep 15.
9
Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.核基质蛋白 MATR3 对 HIV-1 基因在复制和潜伏激活期间转录后调控
mBio. 2018 Nov 13;9(6):e02158-18. doi: 10.1128/mBio.02158-18.
10
Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents.潜伏期逆转剂作用下HIV再激活指标与潜伏库下降之间的关系
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02092-16. Print 2017 May 1.

本文引用的文献

1
CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma.CD137激动剂增强基于纳米颗粒的光热疗法对黑色素瘤的远隔效应。
Nano Res. 2022 Mar;15(3):2300-2314. doi: 10.1007/s12274-021-3813-1. Epub 2021 Oct 12.
2
Anti-Fn14-Conjugated Prussian Blue Nanoparticles as a Targeted Photothermal Therapy Agent for Glioblastoma.抗Fn14共轭普鲁士蓝纳米颗粒作为胶质母细胞瘤的靶向光热治疗剂
Nanomaterials (Basel). 2022 Aug 1;12(15):2645. doi: 10.3390/nano12152645.
3
An Engineered Prussian Blue Nanoparticles-based Nanoimmunotherapy Elicits Robust and Persistent Immunological Memory in a TH-MYCN Neuroblastoma Model.基于工程化普鲁士蓝纳米颗粒的纳米免疫疗法在TH-MYCN神经母细胞瘤模型中引发强大且持久的免疫记忆。
Adv Nanobiomed Res. 2021 Aug;1(8). doi: 10.1002/anbr.202100021. Epub 2021 Mar 13.
4
Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVS.抗氧化应激反应的激活通过线粒体抗病毒信号蛋白同工型 MiniMAVS 重新激活潜伏的 HIV-1。
Front Immunol. 2021 Jun 14;12:682182. doi: 10.3389/fimmu.2021.682182. eCollection 2021.
5
PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function.共封装原卟啉和抗CD25的聚乳酸-羟基乙酸共聚物纳米储库增强了原代自然杀伤细胞的抗病毒和抗肿瘤功能。
Nano Res. 2020 Mar;13(3):736-744. doi: 10.1007/s12274-020-2684-1. Epub 2020 Feb 21.
6
Latency Reversal 2.0: Giving the Immune System a Seat at the Table.潜伏期逆转 2.0:让免疫系统参与其中。
Curr HIV/AIDS Rep. 2021 Apr;18(2):117-127. doi: 10.1007/s11904-020-00540-z. Epub 2021 Jan 12.
7
Engineering precision nanoparticles for drug delivery.工程化精准纳米颗粒用于药物递送。
Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4.
8
Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1.维沙妥莫德,一种 Toll 样受体 7 激动剂,可诱导病毒抑制的人类免疫缺陷病毒 1 感染者的免疫激活。
Clin Infect Dis. 2021 Jun 1;72(11):e815-e824. doi: 10.1093/cid/ciaa1534.
9
CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma.基于CpG包被的普鲁士蓝纳米颗粒的光热疗法联合抗CTLA-4免疫检查点阻断对神经母细胞瘤引发强大的远隔效应。
Transl Oncol. 2020 Oct;13(10):100823. doi: 10.1016/j.tranon.2020.100823. Epub 2020 Jul 8.
10
Nanoparticle-Based Immunoengineered Approaches for Combating HIV.基于纳米颗粒的免疫工程方法用于对抗 HIV。
Front Immunol. 2020 Apr 28;11:789. doi: 10.3389/fimmu.2020.00789. eCollection 2020.

聚肌胞包覆普鲁士蓝纳米颗粒作为一种双重模式的 HIV 潜伏逆转剂。

PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent.

机构信息

Department of Medicine, The George Washington University, 2300 I Street NW, Washington, DC 20037, USA.

The George Washington Cancer Center, The George Washington University, Science & Engineering Hall, Ste 8300, Washington, DC 20052, USA.

出版信息

Nanomedicine (Lond). 2022 Dec;17(29):2159-2171. doi: 10.2217/nnm-2022-0311. Epub 2023 Feb 3.

DOI:10.2217/nnm-2022-0311
PMID:36734362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10061244/
Abstract

To investigate Prussian blue nanoparticles (PBNPs) coated with the synthetic analog of dsRNA polyinosinic-polycytidylic acid (polyIC) for their ability to function as HIV latency reversing agents. A layer-by-layer method was used to synthesize polyIC-coated PBNPs (polyIC-PBNPs). PolyIC-PBNPs were stable and monodisperse, maintained the native absorbance properties of both polyIC and PBNPs and were obtained with high nanoparticle collection yield and polyIC attachment efficiencies. PolyIC-PBNPs were more effective in reactivating latent HIV than free polyIC in a cell model of HIV latency. Furthermore, polyIC-PBNPs were more effective in promoting immune activation than free polyIC in CD4 and CD8 T cells. PBNPs function as efficient carriers of nucleic acids to directly reverse HIV latency and enhance immune activation.

摘要

研究普鲁士蓝纳米颗粒(PBNPs)包裹人工合成双链 RNA 聚肌苷酸-聚胞苷酸(polyIC)类似物,以考察其作为 HIV 潜伏逆转剂的功能。采用层层自组装的方法合成聚肌苷酸包裹的 PBNPs(polyIC-PBNPs)。polyIC-PBNPs 稳定且单分散,保持了 polyIC 和 PBNPs 的固有吸收特性,并且具有高的纳米颗粒收集产率和 polyIC 附着效率。在 HIV 潜伏的细胞模型中,polyIC-PBNPs 比游离 polyIC 更有效地激活潜伏的 HIV。此外,polyIC-PBNPs 在促进 CD4 和 CD8 T 细胞的免疫激活方面比游离 polyIC 更有效。PBNPs 可作为核酸的有效载体,直接逆转 HIV 潜伏并增强免疫激活。